Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Katalyze Data is a specialized technology company that provides data management and analytics solutions tailored for the life sciences and healthcare industries. The company focuses on the 'Data-as-a-Product' (DaaP) paradigm, helping biopharmaceutical organizations transform fragmented R&D and clinical data into high-quality, AI-ready assets. By streamlining data pipelines and ensuring robust governance, Katalyze Data enables faster decision-making and improves efficiency across the drug development lifecycle. Their platform and services support digital transformation initiatives, modernizing legacy data architectures to facilitate advanced analytics and better clinical trial outcomes. The firm is recognized for its expertise in cloud-native data engineering and strategic consulting for complex biological data environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Katalyze Data.